So instead, Rezvani decided to add the CAR gene to natural killer (NK) cells. “These cells are part of the innate immune system, and they’re very good at recognizing and killing cancer cells ...
Clinical relevance: Receptor engineering has significantly advanced NK cell-based cancer immunotherapies. As technical hurdles are overcome, these innovative treatments are poised to revolutionize ...